Mission Driven  is a conversation about startup founders on a mission to address the world’s biggest challenges and how they leverage their social mission for competitive advantage. 
In this episode we talked to Nan Li from Obvious Ventures about his career in venture, Obvious’ approach to ‘world positive’ investing, and the massive emerging opportunity in investing in biology. We cover his views on computational biology and how the confluence of trends such as the explosion in health data coupled with laboratory automation, advanced robotics, and advanced AI infrastructure have the potential to usher in a new era in drug discovery, green chemical production, food production and many more areas. Having made iconic investments in the category, like Zymergen And Recursion Pharma, Nan walked us through why computational biology is so promising and how it represents Obvious Ventures’ strategy in a microcosm.
If you liked this episode, please share and tag us on Twitter:
@BetterVentures
@obviousvc
Ideas for a future episode? Send comments or suggestions to missiondriven@better.vc